Racial and Ethnic Disparities in COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25 Years — 16 U.S. Jurisdictions, January 1–December 31, 2020
Weekly / March 19, 2021 / 70(11);382–388
On March 10, 2021, this report was posted online as an MMWR Early Release.
Miriam E. Van Dyke, PhD1,2,*; Maria C.B. Mendoza, PhD2,*; Wen Li, PhD2; Erin M. Parker, PhD2; Brook Belay, MD2; Elizabeth M. Davis, MA3; Joshua J. Quint, PhD4; Ana Penman-Aguilar, PhD5,†; Kristie E.N. Clarke, MD2,† (View author affiliations)
View suggested citationSummary
What is already known about this topic?
U.S. racial and ethnic minority groups have been disproportionately affected by COVID-19.
What is added by this report?
Racial and ethnic disparities in COVID-19 incidence among persons aged <25 years in 16 U.S. jurisdictions evolved during the pandemic. Disparities were substantial during January–April and generally decreased during May–December, largely because of a greater increase in incidence among White persons, rather than a decline among racial and ethnic minority groups. The largest persistent disparities involved Native Hawaiian and Pacific Islander, American Indian or Alaska Native, and Hispanic persons.
What are the implications for public health practice?
Ensuring equitable and timely access to preventive measures, including testing, safe work and education settings, and vaccination when eligible is important to address racial/ethnic disparities.
The COVID-19 pandemic has disproportionately affected racial and ethnic minority groups in the United States. Whereas racial and ethnic disparities in severe COVID-19–associated outcomes, including mortality, have been documented (1–3), less is known about population-based disparities in infection with SARS-CoV-2, the virus that causes COVID-19. In addition, although persons aged <30 years account for approximately one third of reported infections,§ there is limited information on racial and ethnic disparities in infection among young persons over time and by sex and age. Based on 689,672 U.S. COVID-19 cases reported to CDC’s case-based surveillance system by jurisdictional health departments, racial and ethnic disparities in COVID-19 incidence among persons aged <25 years in 16 U.S. jurisdictions¶ were described by age group and sex and across three periods during January 1–December 31, 2020. During January–April, COVID-19 incidence was substantially higher among most racial and ethnic minority groups compared with that among non-Hispanic White (White) persons (rate ratio [RR] range = 1.09–4.62). During May–August, the RR increased from 2.49 to 4.57 among non-Hispanic Native Hawaiian and Pacific Islander (NH/PI) persons but decreased among other racial and ethnic minority groups (RR range = 0.52–2.82). Decreases in disparities were observed during September–December (RR range = 0.37–1.69); these decreases were largely because of a greater increase in incidence among White persons, rather than a decline in incidence among racial and ethnic minority groups. NH/PI, non-Hispanic American Indian or Alaska Native (AI/AN), and Hispanic or Latino (Hispanic) persons experienced the largest persistent disparities over the entire period. Ensuring equitable and timely access to preventive measures, including testing, safe work and education settings, and vaccination when eligible is important to address racial/ethnic disparities.
Population-based COVID-19 incidence (cases per 100,000 persons) by race and ethnicity, sex, and age was calculated for January 1–December 31, 2020, overall, and for three approximately equal 4-month periods (January 1–April 30, May 1–August 31, and September 1–December 31) using COVID-19 cases reported to CDC’s case-based surveillance system** by jurisdictional health departments. Incompleteness of race and ethnicity data is a widespread challenge in analyses of COVID-19 disparities.†† To minimize the impact of missing data, jurisdictions selected for analyses reported ≥30% of the total number of jurisdictional aggregate cases§§ to CDC and had ≥70% of race and ethnicity information complete among cases reported during January 1–December 31, 2020. Fifteen U.S. states and the District of Columbia were included, with a total of 689,672 cases among persons aged <25 years with information on race and ethnicity and sex.¶¶ Population denominators were obtained from the 2019 U.S. Census Bureau’s Annual County Resident Population Estimates by Age, Sex, Race, and Hispanic Origin.***
Seven racial and ethnic categories (AI/AN, non-Hispanic Asian [Asian], non-Hispanic Black or African-American [Black], NH/PI, White, Hispanic, and non-Hispanic multiple race [multiracial]) and five age categories (0–4, 5–9, 10–14, 15–19, and 20–24 years) were examined. RRs with 95% confidence intervals (CIs) comparing rates by race and ethnicity (combined), age, and/or sex overall and for each period were calculated. Statistical analyses were conducted using SAS software (version 9.4; SAS Institute). Rate ratios with 95% CIs excluding 1.0 were considered to be statistically significant. This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.†††
The sample of 689,672 cases included 15,068 (2%) cases identified during January–April; 177,778 (26%) during May–August and 496,826 (72%) during September–December (Table 1). During January–April, COVID-19 incidence ranged from 35 cases per 100,000 among White persons to 163 per 100,000 among AI/AN persons. Compared with White persons, rates were higher among AI/AN (RR = 4.62), Hispanic (RR = 3.87), NH/PI (RR = 2.49), Black (RR = 2.46), and Asian persons (RR = 1.53) and were approximately equal among multiracial persons (RR = 1.09).
From January–April to May–August, COVID-19 incidence increased among all racial and ethnic groups, ranging from 275 per 100,000 among multiracial persons to 2,418 per 100,000 among NH/PI persons. The largest relative increase occurred among NH/PI persons, with incidence increasing 26-fold, from 88 to 2,418 per 100,000. Rate ratios increased among NH/PI persons but decreased among other racial and ethnic minority groups. During May–August, compared with that among White persons, incidence remained higher among NH/PI (RR = 4.57), Hispanic (RR = 2.82), AI/AN (RR = 1.86), and Black persons (RR = 1.63), but was lower among Asian (RR = 0.77) and multiracial persons (RR = 0.52).
From May–August to September–December, COVID-19 incidence increased among all racial and ethnic groups. The largest relative increase occurred among White persons, with incidence increasing approximately 320%, from 530 to 2,222 cases per 100,000 from May–August to September–December. Disparities decreased among all racial and ethnic minority groups. During September–December, compared with that among White persons, incidence remained higher among NH/PI (RR = 1.69), AI/AN (RR = 1.62), and Hispanic persons (RR = 1.18), but was lower among Asian (RR = 0.57), Black (RR = 0.51), and multiracial persons (RR = 0.37).
Incidence was higher among females than among males during all of 2020 and across periods. Incidence also tended to be lowest among younger children across periods. Lowest incidence was observed among children aged 5–9 years during January–April, those aged 0–9 years during May–August, and those aged 0–4 years during September–December.
During January–December, overall, the highest COVID-19 incidence relative to that among White persons was among NH/PI persons of most age groups, with the largest differences among those aged 0–4 (RR = 4.03) and 5–9 years (RR = 3.21) (Figure) (Supplementary Table, https://stacks.cdc.gov/view/cdc/103733). During January–December, among persons aged ≤14 years, incidence relative to White persons was initially higher among Black and Asian persons and persistently higher among NH/PI, AI/AN, and Hispanic persons; among persons aged 15–24 years, incidence relative to White persons was initially higher among Black, Asian, and multiracial persons, and persistently higher among NH/PI, AI/AN, and Hispanic persons. Overall, during January–December, differences compared with White persons among AI/AN, NH/PI, and Hispanic persons were larger in persons aged ≤14 years than among those aged 15–24 years. Racial and ethnic disparities were similar in magnitude and direction for both females and males across age groups (Table 2).
Discussion
Analysis of CDC’s case-based surveillance data in 16 U.S. jurisdictions during January–December 2020 indicates that racial and ethnic differences in COVID-19 incidence among persons aged <25 years changed over time. Disparities were substantial early in the pandemic among most racial and ethnic minority groups compared with White persons and then decreased over time, largely because of a greater increase in incidence among White persons. Among NH/PI persons, disparities increased from January–April to May–August and then decreased by September–December. The largest persistent disparities in COVID-19 incidence were among NH/PI, AI/AN, and Hispanic persons. Other studies have reported disproportionately higher percentages of COVID-19 cases among Hispanic, Black, Asian, and AI/AN children (4,5); however, no published studies to date have described national COVID-19 incidence among NH/PI children.
Social determinants of health influence racial and ethnic disparities in case incidence.§§§ The large racial and ethnic COVID-19 disparities identified early in the pandemic in this analysis might reflect differential ability to participate in early mitigation measures, such as stay-at-home orders (6). Racial and ethnic minority groups are disproportionately represented in essential work settings, making it difficult for youths and parents to stay at home; a higher likelihood of living in a multigenerational household also increases the risk for household exposures to SARS-CoV-2.¶¶¶ For example, NH/PI persons, a group with some of the largest persistent disparities in this analysis, most often reside in multigenerational homes compared with other racial and ethnic groups (7). Despite on average having lower income and educational attainment, NH/PI persons are often grouped in analyses with Asian persons (8), thereby obscuring disparities influenced by these social determinants of health.
The decrease in racial and ethnic disparities observed over time was largely driven by a greater increase in COVID-19 incidence among White persons, rather than a decrease among racial and ethnic minority groups. This narrowing in differences should be considered in the context of geographic aspects of community spread over time and potential changes in access to or participation in mitigation measures or testing over time by race and ethnicity. For example, future studies could consider whether variations in state-mandated mitigation policies and other aspects of the policy environment led to the observed differential adherence in some mitigation measures by race/ethnicity (9). Further study of whether some testing strategies (e.g., repeat testing of students in some academic settings****) might have been differentially available by race and ethnicity over time is also needed.
The findings in this report are subject to at least five limitations. First, reporting of detailed case data and race and ethnicity to CDC is incomplete. Although this analysis was restricted to 16 jurisdictions with more complete case and race and ethnicity information, 23% of cases from these jurisdictions were missing data on race and ethnicity. Differences in data completeness by race and ethnicity could lead to underestimation of disparities (10). Restriction to 16 jurisdictions also limits the generalizability of these findings, because they are based on only 23% of the national population of persons aged <25 years; in addition, disparities could vary at geographic subdivisions within states. Second, these data likely underestimate the incidence of COVID-19 among persons aged <25 years because individual-level cases reported to CDC represent a portion of jurisdictional aggregate cases and asymptomatic persons are less likely to be tested. Third, cases among racial and ethnic minority groups might be disproportionately underreported given disparities in access to testing, leading to underestimation of disparities. Fourth, potential differences in testing, reporting, and completeness of data by race and ethnicity over time call for caution in interpretation of the observed changes in racial and ethnic disparities in this report. Finally, racial and ethnic disparities in COVID-19 incidence (and changes over time) might not reflect disparities in severe outcomes (1–3).††††
During January 1–December 31, 2020, substantial racial and ethnic disparities in COVID-19 incidence, observed early in the pandemic among persons aged <25 years in 16 jurisdictions, decreased over time, driven largely by a greater increase in reporting of cases among White persons. The largest persistent disparities were among NH/PI, AI/AN, and Hispanic persons. Ensuring equitable and timely access to preventive measures, including testing, safe work and education settings and vaccination when eligible is important to address racial/ethnic disparities.§§§§
Acknowledgments
Courtni Andrews, Office of Minority Health and Health Equity, CDC; Joseph T. Hicks, New Mexico Department of Health, Epidemic Intelligence Service, CDC; Hawaii Department of Health Disease Outbreak Control Division Investigations Team; Oluwatomiloba Ademokun, Jayleen Gunn, Katherine E. Center, COVID-19 Emergency Response Team, CDC.
Corresponding author: Miriam Van Dyke, mpy4@cdc.gov.
1Epidemic Intelligence Service, CDC; 2CDC COVID-19 Response Team; 3New Mexico Department of Health; 4Hawaii State Department of Health; 5Office of Minority Health and Health Equity, CDC.
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
* These authors contributed equally as first authors.
† These authors contributed equally as senior authors.
§ https://covid.cdc.gov/covid-data-tracker/ (accessed February 14, 2021)
¶ Arkansas, District of Columbia, Florida, Hawaii, Kansas, Kentucky, Maine, Massachusetts, Michigan, Minnesota, New Mexico, Oklahoma, Oregon, Utah, Vermont, and Wisconsin.
** CDC implemented a data integration and management platform, Data Collation and Integration for Public Health Event Response (DCIPHER), for use in outbreak responses (https://data.cdc.gov/browse?tags = covid-19). This platform enables jurisdictions to directly enter or import and view their data. Individual-level case report data for COVID-19 cases were accessed through the DCIPHER system on January 27, 2021. Data were classified using the earliest available date related to the illness, specimen collection or reporting to CDC. Case surveillance data were received directly from two jurisdictional health departments (Hawaii State Department of Health and New Mexico Department of Health) for all racial/ethnic groups to allow for separate reporting of NH/PI persons. Data from these two jurisdictions were combined in analyses with data accessed through the DCIPHER system from the 14 other jurisdictions.
†† https://www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html
§§ Aggregate counts from reporting jurisdictions were downloaded through HHS Protect Public Database. https://protect-public.hhs.gov/ (accessed January 27, 2021)
¶¶ Among the identified 919,652 persons aged <25 years with COVID-19 in the 16 jurisdictions, 210,353 (23%) persons were missing information on race and ethnicity and/or sex during January 1–December 31, 2020. Among the 210,353 persons missing information on race and ethnicity and/or sex, 207,659 (99%) were missing information on race and ethnicity. The percentages of persons aged <25 years with COVID-19 in the 16 jurisdictions missing information on race and ethnicity and/or sex were 20.2% during January 1–April 30, 18.9% during May 1–August 31, and 24.3% during September 1–December 31.
*** https://www.census.gov/programs-surveys/popest/technical-documentation/file-layouts.html (accessed August 20, 2020)
††† 45 C.F.R. part 46.102(l)(2), 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 U.S.C. Sect. 552a; 44 U.S.C. Sect. 3501 et seq.
§§§ https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/race-ethnicity.html
References
- Bixler D, Miller AD, Mattison CP, et al.; Pediatric Mortality Investigation Team. SARS-CoV-2–associated deaths among persons aged <21 years—United States, February 12–July 31, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1324–9. https://doi.org/10.15585/mmwr.mm6937e4 PMID:32941417
- Rossen LM, Branum AM, Ahmad FB, Sutton P, Anderson RN. Excess deaths associated with COVID-19, by age and race and ethnicity—United States, January 26–October 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1522–7. https://doi.org/10.15585/mmwr.mm6942e2 PMID:33090978
- Kim L, Whitaker M, O’Halloran A, et al.; COVID-NET Surveillance Team. Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19—COVID-NET, 14 states, March 1–July 25, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1081–8. https://doi.org/10.15585/mmwr.mm6932e3 PMID:32790664
- Bailey LC, Razzaghi H, Burrows EK, et al. Assessment of 135 794 pediatric patients tested for severe acute respiratory syndrome coronavirus 2 across the United States. JAMA Pediatr 2021;175:176–84. https://doi.org/10.1001/jamapediatrics.2020.5052 PMID:33226415
- Hatcher SM, Agnew-Brune C, Anderson M, et al. COVID-19 among American Indian and Alaska Native persons—23 states, January 31–July 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1166–9. https://doi.org/10.15585/mmwr.mm6934e1 PMID:32853193
- Webb Hooper M, Nápoles AM, Pérez-Stable EJ. COVID-19 and racial/ethnic disparities. JAMA 2020;323:2466–7. https://doi.org/10.1001/jama.2020.8598 PMID:32391864
- Raine S, Liu A, Mintz J, Wahood W, Huntley K, Haffizulla F. Racial and ethnic disparities in COVID-19 outcomes: social determinants of health. Int J Environ Res Public Health 2020;17:8115. https://doi.org/10.3390/ijerph17218115 PMID:33153162
- Nguyen AB. Disaggregating Asian American and Native Hawaiian and Other Pacific Islander (AANHOPI) adult tobacco use: findings from wave 1 of the population assessment of tobacco and health (PATH) study, 2013–2014. J Racial Ethn Health Disparities 2019;6:356–63. https://doi.org/10.1007/s40615-018-00532-1 PMID:30610569
- Fisher KA, Barile JP, Guerin RJ, et al. Factors associated with cloth face covering use among adults during the COVID-19 pandemic—United States, April and May 2020. MMWR Morb Mortal Wkly Rep 2020;69:933–7. https://doi.org/10.15585/mmwr.mm6928e3 PMID:32673303
- Labgold K, Hamid S, Shah S, et al. Estimating the unknown: greater racial and ethnic disparities in COVID-19 burden after accounting for missing race and ethnicity data. Epidemiology 2021;32:157–61. https://doi.org/10.1097/EDE.0000000000001314 PMID:33323745
FIGURE. Rate ratios* comparing COVID-19 incidence† among racial and ethnic minority persons to COVID-19 incidence among non-Hispanic White persons, among persons aged <25 years, by age group in three periods — 16 U.S. jurisdictions,§ January 1–December 31, 2020
Abbreviations: AI/AN=American Indian or Alaska Native; NH/PI=Native Hawaiian and Pacific Islander; ref = referent group.
* Rate ratios were calculated during each period and overall. Data used to generate this figure are included in the Supplementary Table, https://stacks.cdc.gov/view/cdc/103733. Rate ratios are not available in situations where data were suppressed because of <20 cases being reported for a given race/ethnicity and age group during a period. During January 1–April 30, 2020, <20 cases were reported for non-Hispanic NH/PI persons aged 0–4, 5–9, 10–14, and 15–19 years. Rate ratios were similar and thus corresponding rate ratio symbols overlap in the figure for the following categories: AI/AN persons aged 15–19 and 20–24 years during May 1–August 31 and September 1–December 31; Black persons aged 5–9 years during January 1–April 30 and May 1–August 31; and NH/PI persons aged 20–24 years during January 1–April 30 and September 1–December 31.
† Rates for each period and for the full period were calculated using the following equation: (cases/population) x 100,000 persons. COVID-19 cases were identified using CDC’s Data Collation and Integration for Public Health Event Response system (https://data.cdc.gov/browse?tags=covid-19 [accessed January 27, 2021]). Case surveillance data were received directly from two jurisdictional health departments (Hawaii State Department of Health and New Mexico Department of Health) for all racial/ethnic groups to allow for separate reporting of NH/PI persons. Population estimates were provided by the 2019 U.S. Census Bureau’s Annual County Resident Population Estimates by Age, Sex, Race, and Hispanic Origin (https://www.census.gov/programs-surveys/popest/technical-documentation/file-layouts.html [accessed August 20, 2020]).
§ Arkansas, District of Columbia, Florida, Hawaii, Kansas, Kentucky, Maine, Massachusetts, Michigan, Minnesota, New Mexico, Oklahoma, Oregon, Utah, Vermont, and Wisconsin.
Suggested citation for this article: Van Dyke ME, Mendoza MC, Li W, et al. Racial and Ethnic Disparities in COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25 Years — 16 U.S. Jurisdictions, January 1–December 31, 2020. MMWR Morb Mortal Wkly Rep 2021;70:382–388. DOI: http://dx.doi.org/10.15585/mmwr.mm7011e1.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.